Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuria Guimera

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMC Research Notes|March 5, 2010
The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervixMichael Odida, Belen Lloveras, Nuria Guimera, et al.
The Journal of Pathology|June 20, 2012
Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancerDaan Geraets, Laia Alemany, Nuria Guimera, et al.
Drug Discovery Today|January 25, 2022
Communicating regulatory high-throughput sequencing data using BioCompute ObjectsCharles Hadley S King, Jonathon Keeney, Nuria Guimera, et al.
Virchows Archiv : an International Journal of Pathology|July 10, 2016
p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomasLlucia Alos, Sofia Hakim, Ana-Belen Larque, et al.
Nature Communications|October 8, 2021
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaquesRamon Roozendaal, Laura Solforosi, Daniel J Stieh, et al.
Plos Biology|January 1, 2019
Enabling precision medicine via standard communication of HTS provenance, analysis, and resultsGil Alterovitz, Dennis Dean, Carole Goble, et al.
Bioanalysis|November 14, 2024
Harmonization of Vaccine Ligand Binding Assays ValidationFrancis Dessy, Ivo Sonderegger, Leslie Wagner, et al.
Bioanalysis|June 22, 2026
Vaccine Ligand Binding Assay Life Cycle Management, Assay Maintenance, Monitoring and TransferJeroen Stoop, James Huleatt, Luc Gagnon, et al.
The Lancet. Oncology|October 19, 2010
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studySilvia de Sanjose, Wim Gv Quint, Laia Alemany, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMC Research Notes|March 5, 2010
The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervixMichael Odida, Belen Lloveras, Nuria Guimera, et al.
The Journal of Pathology|June 20, 2012
Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancerDaan Geraets, Laia Alemany, Nuria Guimera, et al.
Drug Discovery Today|January 25, 2022
Communicating regulatory high-throughput sequencing data using BioCompute ObjectsCharles Hadley S King, Jonathon Keeney, Nuria Guimera, et al.
Virchows Archiv : an International Journal of Pathology|July 10, 2016
p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomasLlucia Alos, Sofia Hakim, Ana-Belen Larque, et al.
Nature Communications|October 8, 2021
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaquesRamon Roozendaal, Laura Solforosi, Daniel J Stieh, et al.
Plos Biology|January 1, 2019
Enabling precision medicine via standard communication of HTS provenance, analysis, and resultsGil Alterovitz, Dennis Dean, Carole Goble, et al.
Bioanalysis|November 14, 2024
Harmonization of Vaccine Ligand Binding Assays ValidationFrancis Dessy, Ivo Sonderegger, Leslie Wagner, et al.
Bioanalysis|June 22, 2026
Vaccine Ligand Binding Assay Life Cycle Management, Assay Maintenance, Monitoring and TransferJeroen Stoop, James Huleatt, Luc Gagnon, et al.
The Lancet. Oncology|October 19, 2010
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studySilvia de Sanjose, Wim Gv Quint, Laia Alemany, et al.
Pageof 1